Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis

CTLA4 Polymorphisms in Minimal Change Nephrotic Syndrome in Children: A Case-Control Study

(2014) Kim Ohl et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Role of Podocyte B7-1 in Diabetic Nephropathy

(2014) P. Fiorina et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Abatacept in B7-1–Positive Proteinuric Kidney Disease

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

The CTLA-4 +49GG genotype is associated with susceptibility for nephrotic kidney diseases

(2013) C. Spink et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Abatacept in B7-1–Positive Proteinuric Kidney Disease

(2013) Chih-Chuan Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Circulating suPAR in Two Cohorts of Primary FSGS

(2012) C. Wei et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice

(2012) T. Ishimoto et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

(2011) Changli Wei et al.   NATURE MEDICINE

Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis

(2010) Eduardo H. Garin et al.   KIDNEY INTERNATIONAL

Minimal change disease: a “two-hit” podocyte immune disorder?

(2010) Michiko Shimada et al.   PEDIATRIC NEPHROLOGY

Intensive and Prolonged Treatment of Focal and Segmental Glomerulosclerosis Recurrence in Adult Kidney Transplant Recipients: A Pilot Study

(2009) G. Canaud et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Urinary CD80 Excretion Increases in Idiopathic Minimal-Change Disease

(2008) E. H. Garin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Activation of Adenosine 2A Receptors Preserves Structure and Function of Podocytes

(2007) A. S. Awad et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY